Skip to content

Canopy News

Featured

Press Release
Clinical

Oral Presentation at ASH 2025 Shows Canopy RTM Cuts Infection-Related Hospitalizations by 52% and Generates Nearly $1M in Annual Savings per 1,000 Patients

New data demonstrate the potential of Canopy's Remote Therapeutic Monitoring (RTM) Platform to improve patient care by reducing serious infections in patients with hematologic malignancies, resulting in an estimated $977,695 in annual savings per 1,000 patients. Canopy, the leader in Enterprise AI for oncology, today announced new findings that highlight how its RTM Platform strengthens outpatient care and reduces infection-related escalations in patients with hematological malignancies.

Read more

Articles

Press Release
Clinical

Canopy Study Selected for Oral Presentation at ASH 2025

Study shows potential of Canopy’s Remote Therapeutic Monitoring Platform to reduce infection-related hospitalizations and ER visits in patients treated for hematological malignancy New York, New York - Canopy, the leader in Enterprise AI for oncology, today announced findings on the potential of its EHR-integrated Remote Therapeutic Monitoring (RTM) Platform to reduce infection-related hospitalization in patients receiving treatment for hematologic malignancies, through earlier identification of infection-related symptoms and associated initiation of outpatient oral antibiotics.

Read more
WVCI
Operational

Canopy and Willamette Valley Cancer Institute and Research Center Announce Partnership to Improve Care Between Visits

WVCI to leverage Canopy's best-in-class AI across patient services to improve care between visits for patients and staff Canopy, the leader in Enterprise AI for oncology, today announced a partnership with Willamette Valley Cancer Institute and Research Center (WVCI), a leader in advanced cancer treatments for over 25 years, to improve care between visits for both patients and staff.

Read more
ASCO Quality Care Symposium
Clinical

Canopy to be Highlighted at ASCO 2025 Quality Care Symposium

Study shows potential of the Canopy Remote Therapeutic Monitoring Platform to enable proactive adherence and toxicity management in patients receiving oral anti-cancer medications New York, New York - Canopy, the leading Enterprise AI Platform for Oncology, today announced findings on the potential for EHR-integrated Remote Therapeutic Monitoring (RTM) to enable practices with medically integrated pharmacies (MIPs) to meet or exceed ASCO/NCODA standards for oral anti-cancer medication (OAM). While traditional approaches rely on phone-based OAM management, the Canopy RTM platform provides an easily scalable, technology-enhanced approach.

Read more

Media Coverage